Trends in the Use of Nonstatin Lipid-Lowering Therapy Among Patients With Coronary Heart Disease: A Retrospective Cohort Study in the Medicare Population 2007 to 2011

Journal of the American College of Cardiology

Volumn 66, Issue 17, 2015, Pages 1864-1872

  Bittner, Vera ^a   Deng, Luqin ^a   Rosenson, Robert S ^b   Taylor, Ben ^c   Glasser, Stephen P ^a   Kent, Shia T ^a   Farkouh, Michael E ^b,d   Muntner, Paul ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c AMGEN INC   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

coronary heart disease; nonstatin lipid lowering therapy; statin

Indexed keywords

ATORVASTATIN; BILE ACID SEQUESTRANT; EZETIMIBE; FIBRIC ACID DERIVATIVE; FLUINDOSTATIN; MEVINOLIN; NICOTINIC ACID; PITAVASTATIN; PRAVASTATIN; ROSUVASTATIN; SIMVASTATIN; ANTILIPEMIC AGENT; HYPOCHOLESTEROLEMIC AGENT;

AFRICAN AMERICAN; AGE; AGE DISTRIBUTION; AGED; ARTICLE; ASIAN AMERICAN; CAUCASIAN; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; CONTROLLED STUDY; ETHNICITY; FEMALE; HEALTH CARE ORGANIZATION; HEALTH INSURANCE; HEART FAILURE; HISPANIC; HUMAN; HYPERCHOLESTEROLEMIA; ICD-9-CM; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; TREND STUDY; VERY ELDERLY; ADULT; CLINICAL PRACTICE; CORONARY DISEASE; DRUG UTILIZATION; HYPERLIPIDEMIAS; TRENDS; UNITED STATES;

ADULT; ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; DRUG UTILIZATION; EZETIMIBE; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; MEDICARE; NIACIN; PRACTICE PATTERNS, PHYSICIANS'; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84945910284     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2015.08.042     Document Type: Article

References (25)

1. C. Baigent, A. Keech, P.M. Kearney, and et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins Lancet 366 2005 1267 1278
2. A.S. Go, D. Mozaffarian, V.L. Roger, and et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association Circulation 129 2014 e28 e292
3. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
4. K.A. Gudzune, A.K. Monroe, R. Sharma, P.D. Ranasinghe, Y. Chelladurai, and K.A. Robinson Effectiveness of combination therapy with statin and another lipid-modifying agent compared with intensified statin monotherapy: a systematic review Ann Intern Med 160 2014 468 476
5. C.P. Cannon, M.A. Blazing, R.P. Giugliano, and et al. Ezetimibe added to statin therapy after acute coronary syndromes N Engl J Med 372 2015 2387 2397
6. C.A. Jackevicius, J.V. Tu, D.T. Ko, N. de Leon, and H.M. Krumholz Use of niacin in the United States and Canada JAMA Intern Med 173 2013 1379 1381
7. C.A. Jackevicius, J.V. Tu, J.S. Ross, D.T. Ko, D. Carreon, and H.M. Krumholz Use of fibrates in the United States and Canada JAMA 305 2011 1217 1224
8. C.A. Jackevicius, J.V. Tu, J.S. Ross, D.T. Ko, and H.M. Krumholz Use of ezetimibe in the United States and Canada N Engl J Med 358 2008 1819 1828
9. L. Lu, H.M. Krumholz, J.V. Tu, J.S. Ross, D.T. Ko, and C.A. Jackevicius Impact of drug policy on regional trends in ezetimibe use Circ Cardiovasc Qual Outcomes 7 2014 589 596
10. L. Lu, H.M. Krumholz, J.V. Tu, J.S. Ross, D.T. Ko, and C.A. Jackevicius Impact of the ENHANCE trial on the use of ezetimibe in the United States and Canada Am Heart J 167 2014 683 689
11. J.S. Ross, S.G. Frazee, S.B. Garavaglia, and et al. Trends in use of ezetimibe after the ENHANCE trial, 2007 through 2010 JAMA Intern Med 174 2014 1486 1493
12. E. Birman-Deych, A.D. Waterman, Y. Yan, and et al. Accuracy of ICD-9-CM codes for identifying cardiovascular and stroke risk factors Med Care 43 2005 480 485
13. T.S. Rector, S.L. Wickstrom, M. Shah, and et al. Specificity and sensitivity of claims-based algorithms for identifying members of Medicare+Choice health plans that have chronic medical conditions Health Serv Res 39 2004 1839 1857
14. D.L. Tirschwell, and W.T. Longstreth Jr. Validating administrative data in stroke research Stroke 33 2002 2465 2470
15. D.R. Miller, M.M. Safford, and L.M. Pogach Who has diabetes? Best estimates of diabetes prevalence in the Department of Veterans Affairs based on computerized patient data Diabetes care 27 Suppl 2 2004 B10 B21
16. S. Schneeweiss, and M. Maclure Use of comorbidity scores for control of confounding in studies using administrative databases Int J Epidemiol 29 2000 891 898
17. P.S. Romano, L.L. Roos, and J.G. Jollis Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: differing perspectives J Clin Epidemiol 46 1993 1075 1079 discussion 1081-90
18. P.P. Toth, C.M. Ballantyne, M.H. Davidson, and et al. Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction J Clin Lipidol 6 2012 180 191
19. J.J. Kastelein, F. Akdim, E.S. Stroes, and et al. Simvastatin with or without ezetimibe in familial hypercholesterolemia N Engl J Med 358 2008 1431 1443
20. A.B. Rossebo, T.R. Pedersen, K. Boman, and et al. Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis N Engl J Med 359 2008 1343 1356
21. R. Peto, J. Emberson, M. Landray, and et al. Analyses of cancer data from three ezetimibe trials N Engl J Med 359 2008 1357 1366
22. W.H. Shrank, N.K. Choudhry, A. Tong, and et al. Warnings without guidance: patient responses to an FDA warning about ezetimibe Med Care 50 2012 479 484
23. Accord Study Group Effects of combination lipid therapy in type 2 diabetes mellitus N Engl J Med 362 2010 1563 1574
24. Aim-High Investigators Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy N Engl J Med 365 2011 2255 2267
25. H.E. Bays, and R.B. Goldberg The 'forgotten' bile acid sequestrants: is now a good time to remember? Am J Ther 14 2007 567 580